AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19843674 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of energy intake
Number of subjects: 29170
Study 19843674 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of energy intake with BMI and physical activity included
Number of subjects: 29170
Study 19843674 — intervention group
Group type: COMPARATOR
Intervention: Energy intake from a FFQ administered approximately five years after entry
Number of subjects: 29170
Study 19843674 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy intake over three 4-year periods
Number of subjects: 29170
Study 17985062 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation with oligosaccharides (1.3 g/250 ml) for 12 weeks
Number of subjects: 74
Study 17985062 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oligosaccharides)
Number of subjects: 74
Study 15271773 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia
Number of subjects: 291
Study 15271773 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic low back pain (CLBP)
Number of subjects: 291
Study 15271773 — intervention group
Group type: COMPARATOR
Intervention: Ankylosing spondylitis
Number of subjects: 291
Study 12611198 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine plus metoclopramide
Number of subjects: 132
Study 12611198 — intervention group
Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 132
Study 12611198 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine > 60 mg/d
Number of subjects: 132
Study 9658729 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (95 IU/kg bid for a minimum of 7 days)
Number of subjects: 71
Study 9658729 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (home treatment)
Number of subjects: 71
Study 8018909 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent cyclic regimen of intermediate-dose methotrexate (MTX) plus 6-mercaptopurine (6MP)
Number of subjects: 811
Study 8018909 — intervention group
Group type: COMPARATOR
Intervention: Conventional continuous administration of low dose of MTX plus 6MP
Number of subjects: 811
Study 8018909 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-drug induction therapy consisting of vincristine (VCR), prednisone (PDN), and L-asparaginase (L-ASP)
Number of subjects: 811
Study 8018909 — intervention group
Group type: COMPARATOR
Intervention: Two-drug therapy consisting of VCR and PDN
Number of subjects: 811
Study 8018909 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen with cranial irradiation
Number of subjects: 811
Study 8018909 — intervention group
Group type: COMPARATOR
Intervention: Regimen without cranial irradiation
Number of subjects: 811
Study 8018909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic administration of intermediate-dose MTX plus 6MP as maintenance therapy
Number of subjects: 811
Study 2465774 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucin-based artificial saliva (Saliva Orthana)
Number of subjects: 30
Study 2465774 — intervention group
Group type: COMPARATOR
Intervention: Non-mucin base
Number of subjects: 30
Study 2465774 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study 4129562 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg dose of Delta 1 testololactone
Number of subjects: 362
Study 4129562 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg dose of Delta 1 testololactone
Number of subjects: 362
Study 4129562 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg dose of Delta 1 testololactone
Number of subjects: 362
Study 30312190 — intervention group
Group type: EXPERIMENTAL
Intervention: Online 12-week walking intervention
Number of subjects: 91
Study 30312190 — intervention group
Group type: COMPARATOR
Intervention: Active control group (pedometer only)
Number of subjects: 91
Study 30957445 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with elongated needle at Zhibian (BL 54) and Shuidao (ST 28), provided once every two days for 2 months.
Number of subjects: 66
Study 30957445 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture with filiform needle at Zhibian (BL 54) and Shuidao (ST 28), provided once every two days for 2 months.
Number of subjects: 66
Study 26988739 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless approach (test group)
Number of subjects: 35
Study 26988739 — intervention group
Group type: COMPARATOR
Intervention: Flap approach (control group)
Number of subjects: 35
Study 26005163 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabies + JE-Accelerated
Number of subjects: 0
Study 26005163 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabies + JE-Standard
Number of subjects: 0
Study 26005163 — intervention group
Group type: COMPARATOR
Intervention: Rabies-Standard
Number of subjects: 0
Study 26005163 — intervention group
Group type: COMPARATOR
Intervention: JE-Standard
Number of subjects: 0
Study 24103072 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive belatacept immunosuppression (MI)
Number of subjects: 304
Study 24103072 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive belatacept immunosuppression (LI)
Number of subjects: 304
Study 24103072 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 304
Study 21641360 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 260
Study 19114905 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (HT) of 33 degrees C for 24 hours
Number of subjects: 70
Study 19114905 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (core temperature kept <38 degrees C)
Number of subjects: 70
Study 19114905 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (HT) of 33 degrees C
Number of subjects: 70
Study 16275171 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal quantitative chest radiography
Number of subjects: 0
Study 15310445 — intervention group
Group type: COMPARATOR
Intervention: Midline incision (Group A)
Number of subjects: 44
Study 15310445 — intervention group
Group type: EXPERIMENTAL
Intervention: Para‐median incision (Group B)
Number of subjects: 44
Study 15310445 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 11771634 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality salience
Number of subjects: 0
Study 11771634 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 9053491 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (5 microg/kg/d for up to 21 days)
Number of subjects: 102
Study 9053491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 9053491 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 102
Study 9053491 — intervention group
Group type: COMPARATOR
Intervention: GM-CSF and Placebo
Number of subjects: 102
Study 8498662 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alfentanil (PCA)
Number of subjects: 32
Study 8498662 — intervention group
Group type: COMPARATOR
Intervention: Epidural alfentanil (PCA)
Number of subjects: 32
Study 8498662 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of SpO2 effects
Number of subjects: 32
Study 8498662 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe desaturation episodes
Number of subjects: 32
Study 3031226 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest radiation therapy (4,800 rad in a split-course scheme)
Number of subjects: 494
Study 3031226 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy without interruption (maintenance chemotherapy with cyclophosphamide and VP-16)
Number of subjects: 494
Study 3031226 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinduction treatment volume or postinduction reduced tumor volume (radiation treatment portals based on tumor extent)
Number of subjects: 494
Study 30243424 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (10 mg/day)
Number of subjects: 76
Study 30243424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 26499920 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide implant
Number of subjects: 117
Study 26499920 — intervention group
Group type: COMPARATOR
Intervention: Systemic therapy with oral corticosteroids and immunosuppression
Number of subjects: 117
Study 24410433 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Prevention plus, Stage 1 treatment)
Number of subjects: 72
Study 24410433 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 23866098 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts, >3 servings/week
Number of subjects: 7216
Study 23866098 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with nuts, >3 servings/week
Number of subjects: 7216
Study 23866098 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 7216
Study 20655125 — intervention group
Group type: EXPERIMENTAL
Intervention: Framing group emphasizing externalities of the uninsured
Number of subjects: 1203
Study 20655125 — intervention group
Group type: EXPERIMENTAL
Intervention: Framing group raising racial and ethnic disparities
Number of subjects: 1203
Study 20655125 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1203
Study 18681988 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg L-theanine + 50 mg caffeine
Number of subjects: 27
Study 18681988 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg caffeine
Number of subjects: 27
Study 18681988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 15930487 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-based meal replacement (MR)
Number of subjects: 90
Study 15930487 — intervention group
Group type: COMPARATOR
Intervention: Milk-based meal replacement (MR)
Number of subjects: 90
Study 12842055 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse continence advisor therapy
Number of subjects: 145
Study 12842055 — intervention group
Group type: COMPARATOR
Intervention: Urogynaecologist treatment
Number of subjects: 145
Study 11067788 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (30 mmol/d Magnosolv‐Granulat)
Number of subjects: 50
Study 8780282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (1, 4, or 8 mg intravenously before induction of anesthesia)
Number of subjects: 873
Study 8780282 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously before induction of anesthesia)
Number of subjects: 873
Study 1621434 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG-anticardiolipin-antibodies in patients with cerebral and peripheral artery disease (group C)
Number of subjects: 123
Study 1621434 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG-anticardiolipin-antibodies in patients with peripheral artery disease only (group B)
Number of subjects: 123
Study 1621434 — intervention group
Group type: EXPERIMENTAL
Intervention: IgM-anticardiolipin-antibodies in all groups
Number of subjects: 123
Study 1621434 — intervention group
Group type: COMPARATOR
Intervention: Control group (group D)
Number of subjects: 123
Study 6517243 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia with thiopental sodium, succinylcholine, alcuronium and halothane
Number of subjects: 74
Study 6517243 — intervention group
Group type: COMPARATOR
Intervention: Catheter epidural anaesthesia (CEA) with bupivacaine
Number of subjects: 74
Study 30943128 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (school-based program)
Number of subjects: 654
Study 30943128 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 654
Study 30021592 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based lifestyle intervention consisting of 15 sessions over 12 months
Number of subjects: 1007
Study 30021592 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based activities (walking groups, kitchen garden training, yoga training)
Number of subjects: 1007
Study 30021592 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer leader (PL) training and ongoing support
Number of subjects: 1007
Study 30021592 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracurricular contacts with PLs
Number of subjects: 1007
Study 25942012 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-minute circuit training (CT-7)
Number of subjects: 96
Study 25942012 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-minute circuit training (CT-14)
Number of subjects: 96
Study 25942012 — intervention group
Group type: COMPARATOR
Intervention: Non-training control group (C)
Number of subjects: 96
Study 25185683 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromoendoscopy-guided endomicroscopy (CGE)
Number of subjects: 162
Study 25185683 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscopy (CC)
Number of subjects: 162
Study 22449804 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol lozenges (6 g/day) for 33 months
Number of subjects: 120
Study 22449804 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment (control group)
Number of subjects: 120
Study 20040165 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner consultations
Number of subjects: 62
Study 20040165 — intervention group
Group type: COMPARATOR
Intervention: GP consultations
Number of subjects: 62
Study 18848670 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick Start (QS) - immediate, directly observed OC pill ingestion in the clinic
Number of subjects: 539
Study 18848670 — intervention group
Group type: COMPARATOR
Intervention: Conventional Start (CS) - conventional initiation of the OC pill
Number of subjects: 539
Study 18848670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 539
Study 16100150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant work rate exercise at 65% of symptom-limited peak work rate
Number of subjects: 27
Study 16100150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant work rate exercise at 75% of symptom-limited peak work rate
Number of subjects: 27
Study 16100150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant work rate exercise at 85% of symptom-limited peak work rate
Number of subjects: 27
Study 16100150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant work rate exercise at 95% of symptom-limited peak work rate
Number of subjects: 27
Study 12854936 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing therapy intervention
Number of subjects: 0
Study 12854936 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11324096 — intervention group
Group type: EXPERIMENTAL
Intervention: EARLY ALLIANCE interventions (integrated set of four programs)
Number of subjects: 0
Study 11324096 — intervention group
Group type: EXPERIMENTAL
Intervention: Universally administered classroom program
Number of subjects: 0
Study 11324096 — intervention group
Group type: EXPERIMENTAL
Intervention: Indicated, peer, reading-mentoring, and family programs
Number of subjects: 0
Study 8983588 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (five different techniques used)
Number of subjects: 0
Study 8983588 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative seriality model of radiation response
Number of subjects: 0
Study 8983588 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional treatment planning system
Number of subjects: 0
Study 1722779 — intervention group
Group type: EXPERIMENTAL
Intervention: HES‐A (500 ml daily for 9 days)
Number of subjects: 60
Study 1722779 — intervention group
Group type: EXPERIMENTAL
Intervention: HES‐B (500 ml daily for 8 days)
Number of subjects: 60
Study 7327086 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice weekly levo‐alpha‐acetylmethadol (LAAM)
Number of subjects: 48
Study 7327086 — intervention group
Group type: COMPARATOR
Intervention: Daily methadone
Number of subjects: 48
Study 30182753 — intervention group
Group type: EXPERIMENTAL
Intervention: D3-Vitamin (100 μg/day)
Number of subjects: 48
Study 30182753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 29110854 — intervention group
Group type: EXPERIMENTAL
Intervention: erlotinib/sorafenib (400mg orally twice daily)
Number of subjects: 53
Study 29110854 — intervention group
Group type: COMPARATOR
Intervention: sorafenib alone
Number of subjects: 53
Study 26151421 — intervention group
Group type: EXPERIMENTAL
Intervention: 600,000 IU intramuscular (i.m.)
Number of subjects: 100
Study 26151421 — intervention group
Group type: EXPERIMENTAL
Intervention: 600,000 IU oral (p.o.)
Number of subjects: 100
Study 26151421 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 IU intramuscular (i.m.)
Number of subjects: 100
Study 26151421 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 IU oral (p.o.)
Number of subjects: 100
Study 22872657 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow intravenous infusion of lactated Ringer solution (1.2 ± 0.3 litres)
Number of subjects: 8
Study 22872657 — intervention group
Group type: COMPARATOR
Intervention: Dehydration (no intravenous infusion)
Number of subjects: 8
Study 22872657 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion
Number of subjects: 8
Study 22872657 — intervention group
Group type: COMPARATOR
Intervention: Normothermic time control
Number of subjects: 8
Study 21084202 — intervention group
Group type: EXPERIMENTAL
Intervention: taliglucerase alfa (novel plant-cell-derived recombinant enzyme)
Number of subjects: 31
Study 19213607 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy I-125 with rectal protection using hyaluronic acid (HA)
Number of subjects: 69
Study 19213607 — intervention group
Group type: COMPARATOR
Intervention: Brachytherapy I-125 alone without HA
Number of subjects: 69
Study 17941364 — intervention group
Group type: EXPERIMENTAL
Intervention: Avène Thermal Spring Water (PDT or IPL)
Number of subjects: 4
Study 17941364 — intervention group
Group type: EXPERIMENTAL
Intervention: NIA 24 (PDT or IPL)
Number of subjects: 4
Study 17941364 — intervention group
Group type: EXPERIMENTAL
Intervention: MimyX cream (PDT or IPL)
Number of subjects: 4
Study 17941364 — intervention group
Group type: EXPERIMENTAL
Intervention: Biafine (PDT or IPL)
Number of subjects: 4
Study 15551893 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg midazolam (1 ml)
Number of subjects: 53
Study 15551893 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg midazolam (1 ml)
Number of subjects: 53
Study 15551893 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (1 ml) as placebo
Number of subjects: 53
Study 14527807 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary load drop
Number of subjects: 11
Study 14527807 — intervention group
Group type: EXPERIMENTAL
Intervention: Known timing of load release
Number of subjects: 11
Study 14527807 — intervention group
Group type: EXPERIMENTAL
Intervention: Unknown timing of load release
Number of subjects: 11
Study 10437420 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (900-1200 mg daily)
Number of subjects: 18
Study 7559310 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD in parents
Number of subjects: 209
Study 7559310 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive disorders in parents
Number of subjects: 209
Study 7559310 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental variables
Number of subjects: 209
Study 7559310 — intervention group
Group type: EXPERIMENTAL
Intervention: Onset of PTSD symptoms
Number of subjects: 209
Study 2322970 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 ml, 1.5 per cent lidocaine hydrochloride injected through the needle prior to catheter insertion
Number of subjects: 200
Study 2322970 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 ml saline injected prior to catheter insertion
Number of subjects: 200
Study 2322970 — intervention group
Group type: COMPARATOR
Intervention: Catheter inserted without previous injection of fluid
Number of subjects: 200
Study 7010262 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiopronin
Number of subjects: 150
Study 7010262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 31479563 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 4106
Study 31479563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride arm (statin users)
Number of subjects: 4106
Study 31479563 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm (statin users)
Number of subjects: 4106
Study 31675942 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Heroes Activity Pack delivered over 6 months
Number of subjects: 81
Study 31675942 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study 31675942 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster level intervention (staff training using Be Active, Eat Healthy)
Number of subjects: 81
Study 31675942 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported outcomes
Number of subjects: 81
Study 28735785 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous length control during root canal preparation
Number of subjects: 44
Study 28735785 — intervention group
Group type: COMPARATOR
Intervention: Separate length determination and root canal preparation (Control)
Number of subjects: 44
Study 25981742 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 10
Study 25981742 — intervention group
Group type: COMPARATOR
Intervention: Stretch exercise (control)
Number of subjects: 10
Study 23513246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (NHF) oxygen therapy at 30 L/min
Number of subjects: 0
Study 23513246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (NHF) oxygen therapy at 40 L/min
Number of subjects: 0
Study 23513246 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (NHF) oxygen therapy at 50 L/min
Number of subjects: 0
Study 21736780 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplemented with 600 μg retinol, 1·0 mg β‐carotene, 100 mg tocopherol, 300 mg ascorbic acid and 200 μg Se (Group A2)
Number of subjects: 254
Study 21736780 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplemented with 900 μg retinol, 1·5 mg β‐carotene, 200 mg tocopherol, 500 mg ascorbic acid and 400 μg Se (Groups B2 and C2)
Number of subjects: 254
Study 21736780 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled (Groups A1, B1, C1)
Number of subjects: 254